HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A distinct bone phenotype in ADPKD patients with end-stage renal disease.

Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is among the most common hereditary nephropathies. Low bone turnover osteopenia has been reported in mice with conditional deletion of the PKD1 and PKD2 genes in osteoblasts, and preliminary clinical data also suggest suppressed bone turnover in patients with ADPKD. The present study compared the bone phenotype between patients with end stage renal disease (ESRD) due to ADPKD and controls with ESRD due to other causes. Laboratory parameters of bone mineral metabolism (fibroblast growth factor 23 and sclerostin), bone turnover markers (bone alkaline phosphatase, tartrate-resistant acid phosphatase 5b) and bone mineral density (BMD, by dual energy x-ray absorptiometry, DXA) were assessed in 518 patients with ESRD, including 99 with ADPKD. Bone histomorphometry data were available in 71 patients, including 10 with ADPKD. Circulating levels of bone alkaline phosphatase were significantly lower in patients with ADPKD (17.4 vs 22.6 ng/mL), as were histomorphometric parameters of bone formation. Associations between ADPKD and parameters of bone formation persisted after adjustment for classical determinants including parathyroid hormone, age, and sex. BMD was higher in skeletal sites rich in cortical bone in patients with ADPKD compared to non-ADPKD patients (Z-score midshaft radius -0.04 vs -0.14; femoral neck -0.72 vs -1.02). Circulating sclerostin levels were significantly higher in ADPKD patients (2.20 vs 1.84 ng/L). In conclusion, patients with ESRD due to ADPKD present a distinct bone and mineral phenotype, characterized by suppressed bone turnover, better preserved cortical BMD, and high sclerostin levels.
AuthorsPieter Evenepoel, Kathleen Claes, Etienne Cavalier, Bjorn Meijers, Peter Stenvinkel, Geert Behets, Magdalena Jankowska, Patrick D'Haese, Bert Bammens
JournalKidney international (Kidney Int) Vol. 95 Issue 2 Pg. 412-419 (02 2019) ISSN: 1523-1755 [Electronic] United States
PMID30665572 (Publication Type: Journal Article)
CopyrightCopyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Biomarkers
  • Bone Morphogenetic Proteins
  • Genetic Markers
  • SOST protein, human
Topics
  • Absorptiometry, Photon
  • Adaptor Proteins, Signal Transducing
  • Adult
  • Aged
  • Animals
  • Biomarkers (blood)
  • Bone Density (physiology)
  • Bone Diseases, Metabolic (blood, etiology, physiopathology)
  • Bone Morphogenetic Proteins (blood)
  • Bone Remodeling (physiology)
  • Bone and Bones (cytology, diagnostic imaging, physiopathology)
  • Case-Control Studies
  • Cilia (pathology, physiology)
  • Female
  • Genetic Markers
  • Humans
  • Kidney Failure, Chronic (blood, pathology)
  • Male
  • Mice
  • Middle Aged
  • Osteoblasts (cytology, pathology)
  • Polycystic Kidney, Autosomal Dominant (complications, pathology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: